BCTX
NASDAQ · Biotechnology
Briacell Therapeutics Corp
$3.51
-0.08 (-2.23%)
Open$3.59
Previous Close$3.59
Day High$3.65
Day Low$3.39
52W High$18.00
52W Low$3.68
Volume—
Avg Volume5.2K
Market Cap38.86M
P/E Ratio—
EPS$-17.14
SectorBiotechnology
Analyst Ratings
Strong Buy
5 analysts
Price Target
+605.1% upside
Current
$3.51
$3.51
Target
$24.75
$24.75
$18.09
$24.75 avg
$34.06
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.36M | 5.82M | 6.86M |
| Net Income | -563,828 | -513,311 | -545,732 |
| Profit Margin | -8.9% | -8.8% | -8.0% |
| EBITDA | -665,396 | -604,117 | -725,268 |
| Free Cash Flow | -534,078 | -494,442 | -500,696 |
| Rev Growth | -7.7% | -7.5% | +13.8% |
| Debt/Equity | 0.28 | 0.30 | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |